More recently, administration of the P2X7 antagonist AZ11645373 or probenecid [an approved drug known to inhibit P2X7 (Bhaskaracharya et al., 2014)], improved survival and recovery to pathogenic influenza infection in a murine model (Rosli et al., 2019). The gene discussed is P2RX7; the disease is influenza.